Topic: exome sequencing

DNA

Genos launches sequencing service to 'crowdsource cures'

Complete Genomics spinout Genos is breaking out of beta testing and unveiling its genetic sequencing service. While it highlights an individual’s right to access his or her own genome, Genos bills itself as a company that uses sequencing to “crowdsource cures.”
Boston

IBM Watson, Broad Institute team up on $50M cancer drug resistance project

IBM Watson is kicking off another oncology partnership, this time with the Broad Institute of MIT and Harvard University. The $50 million tie-up will have the pair examining genome data from 10,000 drug-resistant tumors and cell line studies, with the goal of understanding the drivers behind cancer drug resistance and developing new treatments.

NIH: novel gene may drive progression of rare neuropathy in children

Neuropathy is a condition associated with a progressive decline in motor and sensory function; as such, patients can suffer from a wide range of symptoms, including muscle weakness and pain. National Institutes of Health (NIH) scientists now identify a genetic cause that might reveal itself as a potential drug target for a rare form of neuropathy.